Illumina ILMN
NASDAQ ILMN
$245.18 +16.25 (+7.10%)
At close: Sep 17, 2026 · 4:00 PM EDT

Illumina (ILMN) Gains from Investment Securities (2012 - 2026)

Illumina's (ILMN) quarterly Gains from Investment Securities came in at -$16.0 million in Q2 2026, up 23.81% on a YoY basis from -$12.9 million in Q2 2025, and little changed quarter-over-quarter from -$16.0 million in Q1 2026.

Analysis

Illumina (ILMN) Gains from Investment Securities (2012 - 2026) Analysis & Trends

Illumina (ILMN) has reported Gains from Investment Securities for 11 consecutive years, with -$16.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Gains from Investment Securities rose 23.81% year-over-year to -$16.0 million; the trailing twelve-month figure through Jun 2026 stood at -$18.0 million (up 80.43% YoY), and the FY2025 full-year result was -$18.0 million, up 94.29% from the prior year.
  • Gains from Investment Securities steadied at -$16.0 million in Q2 2026 per ILMN's latest filing, from -$16.0 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $58.0 million in Q4 2023 and bottomed at -$271.0 million in Q2 2024.
  • Historically, Gains from Investment Securities has averaged -$27.1 million across 5 years, with a median of -$11.0 million in 2024.
  • The widest YoY moves for Gains from Investment Securities: up 1700.0% in 2024, down 1034.48% in 2024.
  • Over 5 years, Gains from Investment Securities stood at -$49.0 million in 2022, then jumped by 218.37% to $58.0 million in 2023, then plunged by 118.97% to -$11.0 million in 2024, then jumped by 200.0% to $11.0 million in 2025, then slumped by 245.45% to -$16.0 million in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods registered -$16.0 million, -$16.0 million, and $11.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 -16.00 Mn
Mar 29, 2026 -16.00 Mn
Dec 28, 2025 11.00 Mn
Sep 28, 2025 3.00 Mn
Jun 29, 2025 -21.00 Mn
Mar 30, 2025 -11.00 Mn
Dec 29, 2024 -11.00 Mn
Sep 29, 2024 -49.00 Mn
Jun 30, 2024 -271.00 Mn
Mar 31, 2024 16.00 Mn
Dec 31, 2023 58.00 Mn
Oct 1, 2023 -110.00 Mn
Jul 2, 2023 29.00 Mn
Apr 2, 2023 -1.00 Mn
Apr 3, 2022 -49.00 Mn
Jan 2, 2022 5.00 Mn
Oct 3, 2021 8.00 Mn
Jan 3, 2016 325,000.00
Sep 27, 2015 1.11 Mn
Jun 28, 2015 2.33 Mn